A recent meta-analysis shows a superior risk-benefit profile for NOACs over vitamin K antagonists in patients with Afib and early-stage CKD.
The latest ADA update to its “Living” Standards of Medical Care in Diabetes address the use of dulaglutide (Trulicity) following recent CV outcomes data.
Results from the UK Biobank study reveal favorable findings on the benefit of a healthy lifestyle in older adults with an elevated genetic risk for dementia.
The FDA recently approved a nasal powder formulation of glucagon that simplifies the process of administering treatment to patients who are experiencing severe hypoglycemia but are not able to treat themselves.
A recent study examines the effect of increased physical activity in middle age on all-cause mortality.
The USPSTF recommends the use of preexposure prophylaxis (PrEP) with effective antiretroviral therapy in patients at high risk for HIV acquisition. Who is at high risk? For more information on HIV screening and many other topics in medicine, please visit Univadis.com.
The ADA updated its treatment guidelines for patients with diabetic kidney disease based on the results of the Credence trial.
A new study finds that the American Heart Association’s Life’s Simple 7 strategies confer a significant benefit in reducing heart failure risk.
Yael Waknine of Univadis and Dr. Neil Skolnik, Professor of Family and Community Medicine at Sidney Kimmel Medical College, discuss findings that major bleeds in stroke/TIA rare but higher with clopidogrel + aspirin.
Yael Waknine of Univadis and Dr. Neil Skolnik, Professor of Family and Community Medicine at Sidney Kimmel Medical College, discuss the implications of the CDC confirming the main driver of the 2019 measles outbreak.
Results of the landmark REWIND trial show the efficacy of dulaglutide on patients with diabetes who have or do not have cardiovascular disease. For more information on diabetes and many other topics in medicine, please visit Univadis.com.
The USPSTF has updated its recommendations for HIV screening based on evidence that screening and treatment significantly reduce morbidity and mortality. For more information on HIV screening and many other topics in medicine, please visit Univadis.com.
Dr. Neil Skolnik, Professor of Family and Community Medicine at Sidney Kimmel Medical College, talks with Dr. W. Scott Butsch, Director of Obesity Medicine at the Bariatric and Metabolic Institute at the Cleveland Clinic, about the first FDA-approved weight management medication for adults with BMI of 25-40.
Yael Waknine of Univadis speaks with Dr. Neil Skolnik, Professor of Family and Community Medicine at Sidney Kimmel Medical College, about the FDA's opioid deprescribing guidelines and why tapering the medications has to be done as carefully as prescribing them in the first place.
Yael Waknine of Univadis talks with Dr. Neil Skolnik, Professor of Family and Community Medicine at Sidney Kimmel Medical College, about ACOG’s practice advisory for pregnant women in midst of measles outbreak. Visit Univadis.com for more information.
A recent study examined whether intense workouts could provide any relief to postmenopausal women suffering from hot flashes.
Dr. Neil Skolnik and Dr. Sue Fidler discuss a study that looked at the mental health benefits of playing sports in adolescence.
Two practice-changing articles address the serious health consequences and economic ramifications of physician burnout.
Dr. Neil Skolnik discusses the results of the 30-year Da Qing Diabetes Prevention Outcome Study on the effect of lifestyle interventions on mortality and morbidity.